Drug:
Reaction: WEIGHT INCREASED
20260101 - 20261231
No. 1 - 100
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1 | 26555429 |
US |
2 | |
Weight increased, |
||||
TREPROSTINIL, TREPROSTINIL, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, FUROSEMIDE, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, DULOXETINE HYDROCHLORIDE, EMPAGLIFLOZIN, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, TADALAFIL, SPIRONOLACTONE, OXYGEN, 0XYGEN, ALBUTEROL SULFATE, GABAPENTIN, FERROUS SULFATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, SEMAGLUTIDE, ORAL SEMAGLUTIDE, |
||||
| 2 | 26555677 |
US |
61 | 2 |
Cerebrovascular accident, Brain injury, Road traffic accident, Cardiac disorder, Increased appetite, Weight increased, Intentional product misuse, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 3 | 26555762 |
US |
||
Weight increased, |
||||
TIRZEPATIDE, |
||||
| 4 | 26555776 |
US |
63 | 2 |
Syncope, Pain in extremity, Dyspnoea, Rhinorrhoea, Dizziness, Weight increased, |
||||
SOTATERCEPT-CSRK, |
||||
| 5 | 26555835 |
US |
66 | 2 |
Fluid retention, Weight increased, Alopecia, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 6 | 26556343 |
BR |
32 | 1 |
Crohn^s disease, Weight increased, Product prescribing error, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, |
||||
| 7 | 26556379 |
CA |
45 | |
Blood pressure increased, Weight decreased, Blood pressure diastolic increased, Heart rate increased, Salmonellosis, Weight increased, Myalgia, Arthralgia, Therapeutic response shortened, Off label use, Off label use, Intentional product use issue, Inappropriate schedule of product administration, Off label use, Intentional product use issue, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, |
||||
| 8 | 26556486 |
CA |
40 | 2 |
Abdominal distension, Adverse reaction, Back injury, Bursitis, Coeliac disease, Condition aggravated, Dyspepsia, Fall, Finger deformity, Folliculitis, Gait inability, Gastrointestinal disorder, Gastrooesophageal reflux disease, Grip strength decreased, Headache, Hepatitis, Hypoaesthesia, Injury, Insomnia, Intentional product use issue, Liver function test increased, Malaise, Mobility decreased, Muscular weakness, Musculoskeletal stiffness, Nail disorder, Neck pain, Off label use, Pain in extremity, Pneumonia, Product label confusion, Weight increased, Wheezing, Wound infection, |
||||
RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, |
||||
| 9 | 26556568 |
10 | ||
Seizure, Pulmonary congestion, Pulmonary valve incompetence, Decreased appetite, Constipation, Weight increased, Therapeutic response unexpected, |
||||
FENFLURAMINE, FENFLURAMINE, FENFLURAMINE, PERAMPANEL, CLOBAZAM, ESLICARBAZEPINE ACETATE, |
||||
| 10 | 26556580 |
US |
||
Weight increased, Pain, |
||||
TIRZEPATIDE, |
||||
| 11 | 26556718 |
US |
2 | |
Haematochezia, Myalgia, Weight increased, Alopecia, |
||||
ALIROCUMAB, ALIROCUMAB, |
||||
| 12 | 26556797 |
US |
54 | 1 |
Drug ineffective, Weight increased, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 13 | 26556938 |
US |
||
Weight increased, Swelling face, Drug ineffective, |
||||
ORLISTAT, |
||||
| 14 | 26557007 |
JP |
35 | 2 |
Weight increased, Increased appetite, Akathisia, |
||||
QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, RISPERIDONE, CLONAZEPAM, CLONAZEPAM, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, |
||||
| 15 | 26557027 |
EG |
1 | |
Somnolence, Weight increased, Drug ineffective for unapproved indication, |
||||
QUETIAPINE FUMARATE, QUETIAPINE, DESVENLAFAXINE, DESVENLAFAXINE SUCCINATE, MELATONIN, |
||||
| 16 | 26557032 |
GB |
36 | 2 |
Weight increased, |
||||
ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, |
||||
| 17 | 26557051 |
GB |
33 | 1 |
Medication error, Weight increased, |
||||
ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, VALPROATE SODIUM, |
||||
| 18 | 26557341 |
US |
2 | |
Weight increased, |
||||
QUETIAPINE FUMARATE, QUETIAPINE, |
||||
| 19 | 26557374 |
US |
75 | 2 |
Weight increased, |
||||
TIRZEPATIDE, |
||||
| 20 | 26557407 |
US |
68 | 1 |
Epilepsy, Faeces hard, Gastrointestinal stoma output abnormal, Weight increased, Injection site bruising, Lethargy, Sensitivity to weather change, Drug ineffective, |
||||
TEDUGLUTIDE, TEDUGLUTIDE, TEDUGLUTIDE, TEDUGLUTIDE, |
||||
| 21 | 26557594 |
US |
2 | |
Injection site discolouration, Weight increased, Oedema peripheral, Osteoporosis, Inflammation, |
||||
DUPILUMAB, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, BUPROPION HYDROCHLORIDE, DULOXETINE HYDROCHLORIDE, DULOXETINE, SITAGLIPTIN, LORATADINE, LORATADINE ORAL, PREGABALIN, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 22 | 26557611 |
US |
71 | |
Weight increased, |
||||
TIRZEPATIDE, |
||||
| 23 | 26558150 |
US |
48 | 2 |
Fluid retention, Pleural effusion, Abdominal distension, Dyspnoea, Weight increased, |
||||
DUPILUMAB, |
||||
| 24 | 26558170 |
US |
2 | |
Metabolic dysfunction-associated steatohepatitis, Weight increased, Fluid retention, Headache, Heart rate decreased, Dyspepsia, Epistaxis, Irritable bowel syndrome, |
||||
LEVOKETOCONAZOLE, LEVOKETOCONAZOLE, LEVOKETOCONAZOLE, SEMAGLUTIDE, |
||||
| 25 | 26558415 |
US |
43 | 2 |
Weight increased, Weight decreased, Maternal exposure during pregnancy, Maternal exposure during breast feeding, |
||||
| 26 | 26559312 |
US |
72 | 2 |
Weight increased, Feeling abnormal, |
||||
TIRZEPATIDE, |
||||
| 27 | 26559554 |
AU |
2 | |
Cataract, Brain fog, Memory impairment, Vitreous floaters, Dry eye, Headache, Abdominal distension, Weight increased, Feeling of despair, Depressed mood, Mental disorder, |
||||
TOFACITINIB, UPADACITINIB, |
||||
| 28 | 26559678 |
BR |
16 | 2 |
Crohn^s disease, Antibody test abnormal, Weight increased, Inappropriate schedule of product administration, Drug level decreased, Off label use, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, AZATHIOPRINE, |
||||
| 29 | 26560136 |
US |
48 | 1 |
Weight increased, |
||||
TIRZEPATIDE, |
||||
| 30 | 26560350 |
US |
62 | 1 |
Weight increased, Skin papilloma, Product dose omission in error, |
||||
DUPILUMAB, |
||||
| 31 | 26560492 |
US |
||
Weight increased, Somnolence, |
||||
PALIPERIDONE PALMITATE, PALIPERIDONE PALMITATE, PALIPERIDONE PALMITATE, |
||||
| 32 | 26560511 |
US |
33 | 1 |
Weight increased, |
||||
SPARSENTAN, |
||||
| 33 | 26560607 |
EU |
3 | 2 |
Urinary retention, Weight increased, Constipation, Insomnia, Leukocytosis, Heart rate increased, Rash, Dyskinesia, Blood prolactin increased, |
||||
CLOZAPINE, QUETIAPINE, OLANZAPINE, RISPERIDONE, AMISULPRIDE, BREXPIPRAZOLE, PALIPERIDONE, ARIPIPRAZOLE, |
||||
| 34 | 26560747 |
|||
Seizure, Weight increased, |
||||
FENFLURAMINE, |
||||
| 35 | 26560767 |
|||
Skin discolouration, Carpal tunnel syndrome, Weight increased, Illness, Stress, Sleep apnoea syndrome, Inappropriate schedule of product administration, |
||||
BIMEKIZUMAB, ERGOCALCIFEROL, |
||||
| 36 | 26560866 |
US |
2 | |
Rheumatoid arthritis, Dizziness, Fibromyalgia, Weight increased, |
||||
SEMAGLUTIDE, SEMAGLUTIDE, |
||||
| 37 | 26560873 |
US |
34 | 2 |
Weight increased, Fluid retention, Pain in extremity, Fatigue, Emotional disorder, Tearfulness, Feeling abnormal, Blood pressure decreased, Dizziness, Peripheral swelling, |
||||
SPARSENTAN, SPARSENTAN, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, |
||||
| 38 | 26560953 |
US |
1 | |
Protein urine present, Weight increased, |
||||
SPARSENTAN, |
||||
| 39 | 26560956 |
US |
||
Gait disturbance, Chest discomfort, Weight increased, Chest pain, Visual impairment, Oedema, Disorientation, Dyspnoea, Constipation, Prescribed underdose, Dizziness, |
||||
SPARSENTAN, BUDESONIDE, EVOLOCUMAB, OMEPRAZOLE MAGNESIUM, EMPAGLIFLOZIN, SODIUM ZIRCONIUM CYCLOSILICATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, LOSARTAN, METOPROLOL TARTRATE, METOPROLOL, ALLOPURINOL, ALBUTEROL SULFATE, ALBUTEROL, NITROGLYCERIN, |
||||
| 40 | 26561013 |
US |
50 | 2 |
Weight increased, Dry mouth, Dizziness, Migraine, Dizziness, |
||||
ONABOTULINUMTOXINA, LUMATEPERONE, |
||||
| 41 | 26561073 |
US |
2 | |
Fatigue, Illness, Chromaturia, Weight increased, Product administration error, |
||||
SPARSENTAN, |
||||
| 42 | 26561485 |
US |
64 | 2 |
Off label use, Drug ineffective, Weight increased, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 43 | 26561613 |
US |
70 | 2 |
Constipation, Weight increased, Drug ineffective, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 44 | 26565644 |
51 | 2 | |
Weight increased, Hot flush, |
||||
ALECTINIB HYDROCHLORIDE, |
||||
| 45 | 26569512 |
|||
Treatment failure, Weight increased, Cyst, Neuropathy peripheral, |
||||
HYDROXYZINE, |
||||
| 46 | 26570052 |
|||
Weight increased, Cyst, Neuropathy peripheral, |
||||
OLANZAPINE, OLANZAPINE PAMOATE, |
||||
| 47 | 26570524 |
27 | 2 | |
Stress, Anxiety, Brain fog, Mania, Cough, Psychotic disorder, Weight increased, |
||||
PREDNISONE, FOLIC ACID, |
||||
| 48 | 26550016 |
US |
2 | |
Weight increased, Increased appetite, Food craving, |
||||
TIRZEPATIDE, |
||||
| 49 | 26550067 |
US |
2 | |
Weight increased, |
||||
ELAFIBRANOR, ESCITALOPRAM OXALATE, ESCITALOPRAM, EZETIMIBE, FOLIC ACID, HYDROCHLOROTHIAZIDE, URSODIOL, URSOSIOL, ERGOCALCIFEROL, |
||||
| 50 | 26550353 |
US |
||
Weight increased, Drug ineffective, |
||||
TIRZEPATIDE, |
||||
| 51 | 26550531 |
GB |
25 | 2 |
Rosacea, Hypotension, Hypertension, Dizziness, Loss of consciousness, Chest pain, Hyperhidrosis, Weight increased, |
||||
SERTRALINE, |
||||
| 52 | 26550812 |
US |
60 | 2 |
Weight increased, Drug ineffective, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 53 | 26551117 |
US |
30 | 2 |
Drug ineffective, Osteonecrosis, Off label use, Weight increased, Cushingoid, Transaminases increased, |
||||
METHYLPREDNISOLONE, METHYLPREDNISOLONE, AZATHIOPRINE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, RITUXIMAB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, PREDNISONE, PREDNISONE, DEXAMETHASONE, HUMAN IMMUNOGLOBULIN G, ACETAZOLAMIDE SODIUM, ACETAZOLAMIDE, |
||||
| 54 | 26551211 |
GB |
25 | 2 |
Rosacea, Hypotension, Hypertension, Dizziness, Loss of consciousness, Chest pain, Hyperhidrosis, Weight increased, |
||||
SERTRALINE, |
||||
| 55 | 26551365 |
US |
74 | 2 |
Drug ineffective, Weight increased, Fatigue, |
||||
TIRZEPATIDE, |
||||
| 56 | 26551684 |
US |
82 | 1 |
Weight increased, Depression, Fatigue, |
||||
ENZALUTAMIDE, |
||||
| 57 | 26551704 |
AR |
69 | 1 |
Colostomy, Intestinal obstruction, Skin haemorrhage, Skin disorder, Acne pustular, Epistaxis, Pain of skin, Rash pustular, Skin burning sensation, Dry skin, Off label use, Mucosal disorder, Skin texture abnormal, Weight increased, Pruritus, Scab, Skin exfoliation, Skin reaction, Acne, |
||||
PANITUMUMAB, PANITUMUMAB, PANITUMUMAB, |
||||
| 58 | 26551732 |
US |
79 | 2 |
Colitis ischaemic, Weight increased, International normalised ratio increased, Productive cough, Prescribed underdose, |
||||
NERANDOMILAST, WARFARIN, |
||||
| 59 | 26551744 |
CA |
20 | |
Presyncope, Suffocation feeling, Chest discomfort, Nausea, Dizziness, Dyspnoea, Refusal of treatment by patient, Patient uncooperative, Testicular pain, Aggression, Agitation, Weight increased, Pyrexia, Infusion related reaction, Off label use, Incorrect dose administered, |
||||
INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, |
||||
| 60 | 26551794 |
US |
||
Weight increased, Blood cholesterol increased, |
||||
TIRZEPATIDE, |
||||
| 61 | 26551796 |
|||
Weight increased, |
||||
TIRZEPATIDE, |
||||
| 62 | 26551860 |
US |
2 | |
Weight increased, |
||||
OLAPARIB, |
||||
| 63 | 26552065 |
EU |
3 | 2 |
Urinary retention, Leukocytosis, Heart rate increased, Blood prolactin increased, Rash, Weight increased, Constipation, Insomnia, Dyskinesia, |
||||
BREXPIPRAZOLE, ARIPIPRAZOLE, QUETIAPINE, AMISULPRIDE, OLANZAPINE, CLOZAPINE, RISPERIDONE, PALIPERIDONE, |
||||
| 64 | 26552238 |
US |
71 | 2 |
Cerebrovascular accident, Seizure, Weight increased, Peripheral swelling, Oedema peripheral, Abnormal faeces, Abdominal discomfort, Diarrhoea, Incorrect dose administered, Nausea, |
||||
TEDUGLUTIDE, TEDUGLUTIDE, TEDUGLUTIDE, TEDUGLUTIDE, TEDUGLUTIDE, |
||||
| 65 | 26552425 |
EG |
1 | |
Disturbance in attention, Somnolence, Sedation, Increased appetite, Weight increased, Drug ineffective for unapproved indication, |
||||
QUETIAPINE FUMARATE, QUETIAPINE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, ESZOPICLONE, MELATONIN, |
||||
| 66 | 26552433 |
EU |
2 | |
Weight increased, Insulin resistance, Food craving, Lack of satiety, Impaired driving ability, Visual impairment, Alopecia, Memory impairment, Fatigue, Somnolence, Irritability, Therapeutic response unexpected, Product availability issue, Intentional dose omission, |
||||
ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, QUETIAPINE, LORATADINE, LORATADINE ORAL, |
||||
| 67 | 26552445 |
EG |
2 | |
Disturbance in attention, Extrapyramidal disorder, Somnolence, Sedation, Metabolic disorder, Increased appetite, Weight increased, Drug ineffective for unapproved indication, |
||||
QUETIAPINE FUMARATE, QUETIAPINE, |
||||
| 68 | 26552446 |
EG |
1 | |
Disturbance in attention, Somnolence, Metabolic disorder, Increased appetite, Weight increased, Off label use, |
||||
QUETIAPINE FUMARATE, QUETIAPINE, |
||||
| 69 | 26552456 |
EU |
23 | 2 |
Affective ambivalence, Loss of personal independence in daily activities, Emotional distress, Injection site pain, Weight increased, Drug intolerance, Drug ineffective, |
||||
ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, QUETIAPINE FUMARATE, QUETIAPINE, ARIPIPRAZOLE, ARIPIPRAZOLE, |
||||
| 70 | 26552459 |
EG |
2 | |
Disturbance in attention, Metabolic disorder, Menstrual disorder, Palpitations, Somnolence, Weight increased, Off label use, |
||||
QUETIAPINE FUMARATE, QUETIAPINE, MELATONIN, PROPRANOLOL HYDROCHLORIDE, |
||||
| 71 | 26552473 |
EU |
2 | |
Weight increased, Inflammation, Slow speech, Speech disorder, Contraindicated product prescribed, |
||||
ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, CLOZAPINE, |
||||
| 72 | 26552501 |
EU |
2 | |
Dystonia, Dry skin, Weight increased, Alopecia, |
||||
ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, LITHIUM CARBONATE, |
||||
| 73 | 26552612 |
US |
39 | 2 |
Weight increased, Malaise, |
||||
RAVULIZUMAB, |
||||
| 74 | 26552757 |
US |
69 | 1 |
Barrett^s oesophagus, Pruritus, Appetite disorder, Abdominal distension, Feeling abnormal, Gastrooesophageal reflux disease, Dry skin, Night sweats, Blood pressure increased, Headache, Hot flush, Constipation, Nocturia, Tooth infection, Pain, Middle insomnia, Weight increased, Arthralgia, Asthenia, Myalgia, Product use in unapproved indication, |
||||
ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, RELUGOLIX, RELUGOLIX, RELUGOLIX, RELUGOLIX, ENZALUTAMIDE, ENZALUTAMIDE, ENZALUTAMIDE, ENZALUTAMIDE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE MAGNESIUM, |
||||
| 75 | 26552763 |
US |
58 | 2 |
Weight increased, |
||||
TIRZEPATIDE, |
||||
| 76 | 26552780 |
US |
56 | 2 |
Intrusive thoughts, Confusional state, Weight increased, |
||||
CITALOPRAM, CITALOPRAM HYDROBROMIDE, BUPROPION, OLANZAPINE, OLANZAPINE PAMOATE, |
||||
| 77 | 26552944 |
AR |
67 | 1 |
Colorectal cancer metastatic, Swelling face, Dermatitis allergic, Weight increased, Catheter site infection, Limb injury, Dry skin, Stomatitis, Skin fissures, Catheter site injury, Rash, Pruritus, |
||||
PANITUMUMAB, |
||||
| 78 | 26553049 |
US |
||
Weight increased, |
||||
ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR, |
||||
| 79 | 26553052 |
US |
||
Weight increased, |
||||
ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR, |
||||
| 80 | 26553227 |
US |
59 | 1 |
Weight increased, Product use issue, |
||||
DEGARELIX, GALLIUM GA-68 GOZETOTIDE, ABIRATERONE ACETATE, ABIRATERONE, APIXABAN, PREDNISONE, MELATONIN, |
||||
| 81 | 26553245 |
US |
2 | |
Hospitalisation, Weight increased, Dyspnoea exertional, Fatigue, Photosensitivity reaction, Skin discolouration, |
||||
RUCAPARIB, RUCAPARIB, RUCAPARIB, RUCAPARIB, MAGNESIUM, ERGOCALCIFEROL, METOPROLOL TARTRATE, METOPROLOL, MODAFINIL, |
||||
| 82 | 26553260 |
US |
72 | 2 |
Respiratory syncytial virus infection, Fall, Craniofacial fracture, Haemorrhage, Malignant neoplasm progression, Pulmonary mass, Pancreatic cyst, Nail growth abnormal, Face injury, Post procedural complication, Dysphonia, Musculoskeletal stiffness, Back pain, Musculoskeletal pain, Pain in extremity, Vertigo, Chest discomfort, Weight increased, Fall, Asthma, Hot flush, Breast calcifications, Hair colour changes, Tongue discomfort, Scar, Increased tendency to bruise, Erythema, Dyspnoea, Cough, Fatigue, Diarrhoea, Decreased appetite, Nausea, Alopecia, |
||||
ABEMACICLIB, ABEMACICLIB, ABEMACICLIB, ABEMACICLIB, ABEMACICLIB, ABEMACICLIB, ABEMACICLIB, ABEMACICLIB, ABEMACICLIB, ABEMACICLIB, ABEMACICLIB, ABEMACICLIB, ANASTROZOLE, ANASTROZOLE TABLETS, ANASTROZOLE, ANASTROZOLE TABLETS, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE, GABAPENTIN, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, NAPROXEN SODIUM, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, GUAIFENESIN, NAPROXEN SODIUM, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, GUAIFENESIN, TEZEPELUMAB-EKKO, HELIANTHEMUM NUMMULARIUM FLOWER, CLEMATIS VITALBA FLOWER, IMPATIENS GLANDULIFERA FLOWER, PRUNUS CERASIFERA FLOWER, ORNITHOGALUM UMBELLATUM, AND MALUS DOMESTICA FLOWER, CLEMATIS VITALBA FLOS, HELIANTHEMUM NUMMULARIUM FLOS, IMPATIENS GLANDULIFERA FLOS, ORNITHOGALUM UMBELLATUM FLOS, PRUNUS CERASIFERA FLOS, BIOTIN, IRON, ERGOCALCIFEROL, AZACITIDINE, |
||||
| 83 | 26553274 |
CA |
24 | 2 |
Acne, Anaemia, C-reactive protein increased, Colitis ulcerative, Concomitant disease aggravated, Dizziness, Serum ferritin decreased, Swelling face, Weight increased, Nausea, Labelled drug-drug interaction issue, |
||||
IRON, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, MESALAMINE, PREDNISONE, PREDNISONE, TRAZODONE HYDROCHLORIDE, ETRASIMOD, |
||||
| 84 | 26553427 |
EU |
4 | 1 |
Hyperaldosteronism, Hypokalaemia, Weight increased, Hypertension, |
||||
ARIPIPRAZOLE, |
||||
| 85 | 26553450 |
|||
Weight increased, |
||||
METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, |
||||
| 86 | 26553670 |
US |
39 | 2 |
Weight increased, |
||||
IXEKIZUMAB, |
||||
| 87 | 26553846 |
US |
2 | |
Off label use, Drug ineffective, Weight increased, |
||||
TIRZEPATIDE, |
||||
| 88 | 26553897 |
EU |
2 | |
Therapeutic response increased, Weight increased, |
||||
| 89 | 26554436 |
US |
2 | |
Suicidal ideation, Depression, Somnolence, Dry mouth, Confusional state, Weight increased, Dizziness, |
||||
SEMAGLUTIDE, ORAL SEMAGLUTIDE, AMLODIPINE, |
||||
| 90 | 26554442 |
16 | 2 | |
Weight increased, Peripheral swelling, |
||||
DIAZOXIDE CHOLINE, DIAZOXIDE CHOLINE, CRINECERFONT, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, SOMATROPIN, |
||||
| 91 | 26554451 |
US |
61 | 1 |
Scoliosis, Loss of consciousness, Visual impairment, Eye pain, Overdose, Inappropriate schedule of product administration, Weight increased, Procedural pain, Injection site erythema, Injection site bruising, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 92 | 26554464 |
26 | 2 | |
Dyspnoea exertional, Back pain, Peripheral swelling, Weight increased, |
||||
DIAZOXIDE CHOLINE, DIAZOXIDE CHOLINE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, SOMATROPIN, ERGOCALCIFEROL, FISH OIL, |
||||
| 93 | 26554820 |
US |
||
Weight increased, |
||||
LORLATINIB, |
||||
| 94 | 26554951 |
US |
70 | 2 |
Hunger, Abdominal discomfort, Nausea, Weight increased, Drug ineffective, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 95 | 26558218 |
68 | 2 | |
Weight increased, Hepatic steatosis, Blood glucose increased, Hypertension, Neuropathy peripheral, Arthralgia, Cough, Therapy interrupted, |
||||
ALECTINIB HYDROCHLORIDE, |
||||
| 96 | 26558274 |
64 | 1 | |
Condition aggravated, Hypertrophic cardiomyopathy, Weight increased, Procedural pain, Fatigue, Pain, |
||||
MAVACAMTEN, CARVEDILOL, |
||||
| 97 | 26564798 |
36 | 1 | |
Peripheral swelling, Weight increased, |
||||
MAVACAMTEN, |
||||
| 98 | 26548990 |
US |
42 | 2 |
Weight increased, Nausea, Drug ineffective, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 99 | 26549014 |
US |
77 | 1 |
Toothache, Confusional state, Weight increased, |
||||
VIBEGRON, |
||||
| 100 | 26549024 |
CA |
38 | |
Asthma, Blood pressure increased, Blood urea decreased, Body mass index increased, Body temperature decreased, Dyspnoea, Forced expiratory volume decreased, Glomerular filtration rate decreased, Malaise, Middle insomnia, Obesity, Obstructive airways disorder, Oropharyngeal pain, Pain, Pneumonia, Psoriatic arthropathy, Reversible airways obstruction, Sensitivity to weather change, Swelling, Swelling face, Total lung capacity decreased, Weight decreased, Pyrexia, Urticaria, Sinusitis, Pruritus, Arthralgia, Cardiac failure congestive, Diarrhoea, Nasopharyngitis, Influenza, Cough, Anaphylactic reaction, Drug hypersensitivity, Weight increased, Respiratory disorder, Product dose omission issue, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, SECUKINUMAB, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, CICLESONIDE, DIPHENHYDRAMINE HYDROCHLORIDE, CICLESONIDE, RABEPRAZOLE, RANITIDINE, SERTRALINE HYDROCHLORIDE, MONTELUKAST SODIUM, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-04-28